Blog
RSS FeedPosted by Michael Wonder on 17 Jul 2019
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 11 Jul 2019
Trump abandons drug pricing proposal that would have ended certain drug rebates
11 July 2019 - The Trump administration on Wednesday abandoned one of its signature drug-pricing efforts: a ban on many ...
Posted by Michael Wonder on 11 Jul 2019
How Australia could almost eradicate H.I.V. transmissions
10 July 2019 - It took universal health care, political will and a health campaign designed to terrify the public, ...
Posted by Michael Wonder on 11 Jul 2019
Decision for funding in the neurology, immunosuppression, diabetes and anti-thrombotic therapy areas
11 July 2019 - PHARMAC is pleased to announce the approval of a decision relating to medicines in the neurology, ...
Posted by Michael Wonder on 11 Jul 2019
Neurocrine Biosciences announces FDA acceptance of new drug application for opicapone as an adjunctive treatment for patients with Parkinson's disease
10 July 2019 - New drug application based on data from 38 clinical studies, including two Phase III studies, with more ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder
10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma
10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...
Posted by Michael Wonder on 11 Jul 2019
Reforming the Orphan Drug Act for the 21st century
11 July 2019 - The pharmaceutical market has undergone radical changes, including markedly increased prices for rare-disease drugs. ...
Posted by Michael Wonder on 11 Jul 2019
Horizon Therapeutics submits teprotumumab biologics license application for the treatment of active thyroid eye disease
10 July 2019 - Horizon Therapeutics announced today that it has submitted a biologics license application to the U.S. FDA ...
Posted by Michael Wonder on 10 Jul 2019
Canada’s labour leaders encourage premiers to embrace universal pharmacare
10 July 2019 - The presidents of federations of labour from across the country are in Saskatoon during the Council ...
Posted by Michael Wonder on 10 Jul 2019
Biomarker-based cancer diagnostics: German pricing regulator sets high validation and reimbursement standards for novel diagnostic methods
10 July 2019 - On 20 June 2019, for the first time, the German Federal Joint Committee (G-BA), made the resolution ...
Posted by Michael Wonder on 10 Jul 2019
FDA announces new efforts to expedite generic drug development and marketing to improve patient access to medicines
10 July 2019 - Today, the U.S. FDA announced a draft guidance, Harmonizing Compendial Standards With Drug Application Approval Using the ...
Posted by Michael Wonder on 10 Jul 2019
A Supreme Court ruling may have made it harder to get some info from the FDA
9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...
Posted by Michael Wonder on 10 Jul 2019
GOP senators raise concerns over potential deal to lower drug prices
9 July 2019 - Republican Senators and Trump administration officials met Tuesday morning to debate a potential deal to lower ...
Posted by Michael Wonder on 10 Jul 2019
U.S. appeals court signals sympathy to bid to strike down Obamacare
9 July 2019 - A federal appeals court panel appeared sympathetic on Tuesday to Republican efforts to overturn Obamacare, expressing skepticism ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...